Media

Media contact

Media library

Fast facts

Page last modified 01 October 2018

You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.

Choose region and then country

Other Lundbeck sites

Global contacts

Media

Welcome to the media section

Latest releases

Takeda and Lundbeck submit New Drug Application (NDA) for vortioxetine in Japan for the treatment of Major Depressive Disorder (MDD)

Lundbeck realized 14% growth in revenue (local currencies) and 83% growth in EPS

Lundbeck brings potential new biologic treatment of Parkinson’s disease into clinical development

Dr. Deborah Dunsire named new President and CEO of Lundbeck

Lundbeck starts clinical development of potential new treatment of Parkinson's disease

Media contact

General press enquiries, please call +45 3643 4000

Media library

Access visual aids for stories about Lundbeck

Fast facts

Get a quick overview of Lundbeck and our business